TABLE 1.
Sociodemographic, Prognostic, Treatment, Performance Status, and Emotional Distress Variables for the Assessment Only and Intervention Study Arms at the Time of Accrual/Randomization
| Total (N5227) |
Assessment Only (n5113) |
Intervention (n5114) |
||||
|---|---|---|---|---|---|---|
| Variable | Mean (SD) | % | Mean (SD) | % | Mean (SD) | % |
| Sociodemographic | ||||||
| Age, y | ||||||
| <35 | 5 | 4 | 6 | |||
| 5–49 | 44 | 42 | 46 | |||
| 0–69 | 45 | 46 | 44 | |||
| >69 | 6 | 8 | 4 | |||
| Race (white) | 90 | 90 | 90 | |||
| Partner status (partnered) | 74 | 72 | 75 | |||
| Education, y | 14.75 (2.74) | 14.34 (2.57) | 15.16 (2.85) | |||
| Family income ($K/y) | 67.98 (71.41) | 66.30 (84.68) | 69.64 (55.59) | |||
| Prognostic | ||||||
| Stage (II vs III, %II) | 90 | 92 | 89 | |||
| Tumor size, cm | 3.02 (1.77) | 2.91 (1.75) | 3.12 (1.78) | |||
| No. of positive lymph nodes | 3.05 (5.45) | 3.06 (5.27) | 3.04 (5.64) | |||
| ER/PR positive | 68 | 68 | 68 | |||
| Histologic grade | ||||||
| Poorly differentiated | 42 | 43 | 41 | |||
| Moderately differentiated | 51 | 53 | 50 | |||
| Well differentiated | 7 | 4 | 9 | |||
| Histologic type | ||||||
| Ductal | 75 | 77 | 73 | |||
| Lobular | 13 | 11 | 16 | |||
| Other | 12 | 12 | 11 | |||
| Premenopausal status | 54 | 52 | 55 | |||
| Treatment | ||||||
| Surgery (lumpectomy) | 43 | 43 | 43 | |||
| Chemotherapy* | 84 | 85 | 83 | |||
| Radiotherapy* | 54 | 51 | 56 | |||
| Hormonal therapy* | 75 | 80 | 71 | |||
| KPS† | 85.11 (7.95) | 86.55 (6.91) | 83.68 (8.65) | |||
| Mood states (POMS)† | 36.32 (34.26) | 31.38 (32.11) | 41.42 (35.67) | |||
SD indicates standard deviation; ER, estrogen receptor status; PR, progesterone receptor status; KPS, Karnofsky performance status; POMS, The Profile of Mood States.
*
Treatment received after randomization; all surgery preceded randomization.
†
Significant group difference, P <.05.